-
Drug Manufacturing Stocks Rally Up to 89% in Six Months: Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma as Nifty Pharma Hits a Record on 9 November 2026
- November 13, 2026
- Posted by: Neeraj Pandey
- Category: News
No Comments
Drug manufacturing stocks such as Laurus Labs, Gland Pharma and Divi’s have risen up to 89% in six months as Nifty Pharma hit a record. Data, drivers and risks.
-
3 Telecom and Enterprise IT Services Provider, Active Ingredients and Formulations Maker and Hair Oil and Edible Oil Brand Owner Stocks With a Strong Future Roadmap: Tech Mahindra, Laurus Labs and Marico
- November 4, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
IT Services, API and Hair Oil Stocks with a strong future roadmap: Tech Mahindra, Laurus Labs and Marico. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.
-
3 Specialty Performance Chemicals Maker, Contract Drug Maker and Active Ingredients and Formulations Company Stocks With a Strong Future Roadmap: Clean Science and Technology, Innova Captab and Laurus Labs
- November 2, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Specialty Chemical, Contract Drug and API Stocks with a strong future roadmap: Clean Science and Technology, Innova Captab and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 30 October 2026.
-
3 Branded Generics Pharma Company, Pharma Formulations and Custom Synthesis Company and Integrated Apparel Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Laurus Labs and KPR Mill
- October 30, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Generic, Custom Pharma and Apparel Stocks with a strong future roadmap: Emcure Pharmaceuticals, Laurus Labs and KPR Mill. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.
-
3 Cardiovascular Medicines Leader, Innovation Led Generics Company and Anti Retroviral Ingredients Specialist Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Laurus Labs
- October 29, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Heart Care Medicine and API Pharma Stocks with a strong future roadmap: Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.
-
3 Branded Generics Company, Specialty Prescription Brand Owner and Active Ingredients Producer Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Ajanta Pharma and Laurus Labs
- October 29, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Branded Generics, Specialty and API Pharma with a strong future roadmap: Lincoln Pharmaceuticals, Ajanta Pharma and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Emerging Markets Generics Company, Global Generics Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs
- October 28, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Emerging Market, Global Pharma and API Stocks with a strong future roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.
-
3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma
- October 26, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Fermentation API, Contract Pharma and OTC Stocks with a strong future roadmap: Concord Biotech, Laurus Labs and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals
- October 26, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
API, Excipient and Generic Pharma Stocks with a strong future roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
- 1
- 2